Tag: Japan

If this innovative approach is proven to be successful, it may also be applicable for developing vaccines against other pathogens in the CEPI portfolio

Delay in launch of indigenous COVID-19 vaccines by Japanese pharma will impact domestic market potential

Japanese researchers develop a nanoparticle-based drug delivery system from corn/maize to target cancer cells

Scientists develop a new candidate vaccine that improves obesity-related disorders and may be economical

Using a photocatalyst, scientists have identified the factors behind racemization process of chiral sulfoxides......................

This edition of Chat with BioVoice features Suneela Thatte, Vice President & Head, R & D Solutions, IQVIA India who believes that the demand for faster and better drug development brought on by the pandemic is only going to accelerate the adoption of digital technologies........................

ILUMYA is the first IL-23 inhibitor to complete five years of study based on a pooled analysis of two Phase 3 efficacy and safety extension trials in moderate-to-severe plaque psoriasis.......................

The drug offers a new treatment option with only one injection every 12 weeks for Japanese patients who struggle everyday with the chronic nature of plaque psoriasis..........................

In a webinar, the top Indian officials presented the sectoral view and the investment opportunities in the pharmaceutical and medical device industry in India to Japanese industry representatives.......................

C-CAMP – BNV Innovation Hub (CBIH) is calling for applications from Indian bio startups for funding support of up to 300,000 USD or approximately 2.1 Cr INR per startup....................